These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 6414694

  • 1. The development of mesna for regional detoxification.
    Brock N, Pohl J.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():33-43. PubMed ID: 6414694
    [No Abstract] [Full Text] [Related]

  • 2. Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Brock N, Pohl J, Stekar J.
    J Cancer Res Clin Oncol; 1981 Sep; 100(3):311-20. PubMed ID: 6792207
    [Abstract] [Full Text] [Related]

  • 3. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N, Pohl J.
    IARC Sci Publ; 1986 Sep; (78):269-79. PubMed ID: 3108156
    [Abstract] [Full Text] [Related]

  • 4. Protecting the bladder from cyclophosphamide with mesna.
    Finn GP, Sidau B, Shaw IC.
    N Engl J Med; 1986 Jan 02; 314(1):61. PubMed ID: 3079620
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity.
    Cavalletti E, Tofanetti O, Zunino F.
    Cancer Lett; 1986 Jul 02; 32(1):1-6. PubMed ID: 3091245
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
    Luce JK, Simons JA.
    Med Pediatr Oncol; 1988 Jul 02; 16(6):372-4. PubMed ID: 3143903
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis.
    Ehrlich RM, Freedman A, Goldsobel AB, Stiehm ER.
    J Urol; 1984 May 02; 131(5):960-2. PubMed ID: 6423841
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna.
    Schmähl D, Habs MR.
    Cancer Treat Rev; 1983 Sep 02; 10 Suppl A():57-61. PubMed ID: 6414697
    [No Abstract] [Full Text] [Related]

  • 14. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats.
    Ozcan A, Korkmaz A, Oter S, Coskun O.
    Arch Toxicol; 2005 Aug 02; 79(8):461-5. PubMed ID: 15800758
    [Abstract] [Full Text] [Related]

  • 15. Prophylaxis of haemorrhagic cystitis due to cyclophosphamide-conditioning for bone marrow transplantation.
    Link H, Neef V, Niethammer D, Wilms K.
    Blut; 1981 Nov 02; 43(5):329-30. PubMed ID: 6799018
    [No Abstract] [Full Text] [Related]

  • 16. Mesna and oxazaphosphorine cancer chemotherapy.
    Shaw IC.
    Cancer Treat Rev; 1987 Dec 02; 14(3-4):359-64. PubMed ID: 3125971
    [No Abstract] [Full Text] [Related]

  • 17. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences].
    Schmähl D, Habs M, Tacchi AM.
    Urologe A; 1984 Sep 02; 23(5):291-6. PubMed ID: 6438859
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.